Tobias Ettl

5PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Oral implantology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 10, 2026
A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

|Mar 19, 2026
Increased LAG-3, TIM-3, and IDO1 Expression Is Associated With Oral Squamous Cell Carcinoma in Never Smokers and Never Drinkers.

Mathias Fiedler, Alisa Off, Jonas Eichberger

|Jan 09, 2026
Perioperative Piperacillin/Tazobactam Reduces Early Onset SSI in Preirradiated Patients Undergoing Microvascular Head and Neck Reconstruction.

Johannes G Schuderer, Florian Hoferer, Jonas Eichberger

|Oct 28, 2024
Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-Drinkers.

Mathias Fiedler, Alisa Off, Andreas Gärtner

|May 05, 2021
Significance of site-specific radiation dose and technique for success of implant-based prosthetic rehabilitation in irradiated head and neck cancer patients-A cohort study.

Franziska Wolf, Steffen Spoerl, Maximilian Gottsauner

Pageof 1

Frequent Collaborators

4 joint publications

Mathias Fiedler